A Phase I/II Study of M3814 and Avelumab in Combination with Hypofractionated Radiation in Patients with Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

Go Back to All Clinical Trials

A Phase I/II Study of M3814 and Avelumab in Combination with Hypofractionated Radiation in Patients with Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

Brief description of study

Clinical Study Identifier: s20-01391

ClinicalTrials.gov Identifier: NCT04068194

Principal Investigator: Nina Beri.

Other Investigators: Theresa Ryan, Jennifer Wu, Daniel J Becker, Cristian C Papazoglu Statescu, Paul E. Oberstein, Kristen Spencer, Colin Hill, Keriann M Scavone, Benjamin Cooper, Jennifer Chuy, Rafael Winograd, Shun Yu, Mary Lynn R Nierodzik, Fauzia Shaikh.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Perlmutter Cancer Center

Clinical Trials & Research Studies